Patent · US Active

Pharmaceutical composition of apixaban

US11510909B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2018
Grant dateNov 29, 2022
Priority date
Expiry dateFeb 5, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/4545
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to a stable, reproducible and bioequivalent apixaban compositions, wherein the composition comprising apixaban having a D90 particle size of more than 100 microns, preferably between 300 and 1000 microns, and more preferably between 350 and 800 microns, and further comprising one or more pharmaceutically acceptable excipients. The present disclosure further provides a process for preparation of a pharmaceutical composition comprising apixaban by wet granulation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.